Examination of Provider and Patient Knowledge, Beliefs, and Preferences in Integrative Oncology at a National Cancer Institute-Designated Comprehensive Cancer Center.
barriers
comprehensive cancer center
facilitators
implementation science
integrative oncology
survivorship
Journal
Integrative medicine reports
ISSN: 2768-3222
Titre abrégé: Integr Med Rep
Pays: United States
ID NLM: 9918402367706676
Informations de publication
Date de publication:
2022
2022
Historique:
accepted:
19
05
2022
entrez:
15
8
2022
pubmed:
16
8
2022
medline:
16
8
2022
Statut:
epublish
Résumé
The use of integrative approaches for symptom management is highly prevalent among patients undergoing cancer treatment and among cancer survivors and is increasingly endorsed by clinical practice guidelines. However, access to and implementation of integrative oncology (IO) approaches are hindered by barriers at multiple levels, including logistic, geographic, financial, organizational, and cultural barriers. The goal of this mixed-method study was to examine oncology provider and patient knowledge, beliefs, and preferences in IO to identify facilitators, barriers, and recommendations for implementation of IO modalities. Data sources included patient surveys and provider semistructured interviews. Patients were in active treatment ( The primary interests reported among actively treated patients and survivors were massage therapy, acupuncture, and wellness/exercise. Most patients expressed interest in both group and individual sessions and in telehealth or virtual reality options. Emergent themes from provider interviews identified barriers and facilitators to implementing IO approaches in both the internal and external settings, as well as for the implementation process. The emphasis on mind-body interventions as
Identifiants
pubmed: 35966884
doi: 10.1089/imr.2021.0004
pii: 10.1089/imr.2021.0004
pmc: PMC9372903
doi:
Types de publication
Journal Article
Langues
eng
Pagination
66-75Subventions
Organisme : NCCIH NIH HHS
ID : K01 AT010488
Pays : United States
Informations de copyright
© Jennifer S. Mascaro et al., 2022; Published by Mary Ann Liebert, Inc.
Déclaration de conflit d'intérêts
No competing financial interests exist.
Références
PLoS One. 2016 Nov 3;11(11):e0165801
pubmed: 27812163
Cancer. 2015 Jul 15;121(14):2431-8
pubmed: 26011157
Arch Intern Med. 2002 May 27;162(10):1176-81
pubmed: 12020190
Support Care Cancer. 2021 Oct;29(10):5777-5785
pubmed: 33740131
J Altern Complement Med. 2019 Aug;25(8):809-813
pubmed: 31274335
J Cancer Surviv. 2011 Mar;5(1):8-17
pubmed: 20924711
Integr Cancer Ther. 2012 Sep;11(3):187-203
pubmed: 22019489
J Natl Cancer Inst. 2018 Jan 1;110(1):
pubmed: 28922780
J Altern Complement Med. 2021 Mar;27(S1):S89-S98
pubmed: 33788601
J Altern Complement Med. 2019 Jul;25(7):733-739
pubmed: 31314561
Support Care Cancer. 2005 Oct;13(10):806-11
pubmed: 15711946
Pilot Feasibility Stud. 2019 Jun 20;5:80
pubmed: 31245024
Integr Cancer Ther. 2018 Jun;17(2):380-387
pubmed: 27585628
J Clin Oncol. 1996 Feb;14(2):671-9
pubmed: 8636786
J Oncol Pract. 2019 Jan;15(1):7-14
pubmed: 30629900
Evid Based Complement Alternat Med. 2011;2011:790951
pubmed: 19098296
Eur J Cancer. 2012 Nov;48(17):3133-9
pubmed: 22633625
J Natl Cancer Inst. 2009 Jun 16;101(12):860-8
pubmed: 19509357
Acupunct Med. 2021 Oct;39(5):461-470
pubmed: 33307728
Support Care Cancer. 2004 Nov;12(11):797-804
pubmed: 15378417
J Altern Complement Med. 2018 Sep/Oct;24(9-10):1016-1017
pubmed: 30247966
Cancer. 2009 Nov 15;115(22):5349-61
pubmed: 19753617
Integr Cancer Ther. 2005 Dec;4(4):274-86
pubmed: 16282504
Implement Sci. 2009 Aug 07;4:50
pubmed: 19664226
J Altern Complement Med. 2021 Nov;27(11):1011-1013
pubmed: 34339283
Support Care Cancer. 2021 Aug;29(8):4191-4194
pubmed: 33772364
Integr Cancer Ther. 2013 Mar;12(2):103-12
pubmed: 22710259
Cancer Clin Oncol. 2013 Nov;2(2):81-92
pubmed: 26640610
J Natl Cancer Inst Monogr. 2017 Nov 1;2017(52):
pubmed: 29140493
Health Care Financ Rev. 2008 Summer;29(4):41-56
pubmed: 18773613
J Clin Oncol. 2014 Dec 20;32(36):4095-101
pubmed: 25403205
BMJ Open. 2020 Mar 9;10(3):e034141
pubmed: 32156765
Psychol Med. 2010 Nov;40(11):1797-810
pubmed: 20085667
Support Care Cancer. 2021 Sep;29(9):5313-5321
pubmed: 33660077